Xu-Monette, Z. Y., Li, L., Byrd, J. C., Jabbar, K. J., Manyam, G. C., de Winde, C. M., … Young, K. H. (2016). Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. BLOOD, 128(26), 3083–3100. https://doi.org/10.1182/blood-2016-05715094

Xu-Monette, Zijun Y., Ling Li, John C. Byrd, Kausar J. Jabbar, Ganiraju C. Manyam, Charlotte Maria de Winde, Michiel van den Brand, et al. “Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.” BLOOD 128, no. 26 (December 29, 2016): 3083–3100. https://doi.org/10.1182/blood-2016-05715094.

Xu-Monette ZY, Li L, Byrd JC, Jabbar KJ, Manyam GC, de Winde CM, et al. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. BLOOD. 2016 Dec 29;128(26):3083–100.

Xu-Monette, Zijun Y., et al. “Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.” BLOOD, vol. 128, no. 26, AMER SOC HEMATOLOGY, Dec. 2016, pp. 3083–100. Wos, doi:10.1182/blood-2016-05715094.

Xu-Monette ZY, Li L, Byrd JC, Jabbar KJ, Manyam GC, de Winde CM, van den Brand M, Tzankov A, Visco C, Wang J, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, Huh J, Ponzoni M, Ferreri AJM, Moller MB, Parsons BM, Winter JN, Wang M, Hagemeister FB, Piris MA, van Krieken JH, Medeiros LJ, Li Y, van Spriel AB, Young KH. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. BLOOD. AMER SOC HEMATOLOGY; 2016 Dec 29;128(26):3083–3100.